•  
  •  
  •  
  •  

2026-05-15 03:58:46

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Deep Industries Ltd consolidated Q4 FY2025-26 loss at Rs. 14.35 crores
  • Data Patterns India Ltd Q4FY26 PAT climbs to Rs. 138.38 crores
  • KRBL Ltd posts consolidated PAT of Rs. 155.38 crores in Q4 FY26
  • Pitti Engineering Ltd consolidated Q4 FY2026 profit declines to Rs. 26.61 crores
  • Mukand Ltd reports consolidated PAT of Rs. 554.98 crores in Q4 FY2026

Keywords Selected:  Injection

Stock Report

  • Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
  • Biocon Pharma Limited Receives Health Canada Approval for Micafungin for Injection, USP, 50 MG and 100 MG
  • Caplin Steriles Ltd gets USFDA approval for Calcium Gluconate Injection
  • OneSource Supports Second Generic Semaglutide Approval in Canada
  • OneSource's Partner Dr. Reddy's Laboratories receives Health Canada Approval for Generic Semaglutide Injection
  • Orbicular's Partner secures tentative U.S. ANDA approval for a generic version of Semaglutide Injection, supported by OneSource as CDMO partner
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Methotrexate Injection USP
  • Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection
  • Sun Pharma launches its semaglutide injection under the brand names, Noveltreat and Sematrinity in India
  • Zydus launches Semaglutide Injection in an innovative, reusable multi-dose pen device in India
  • NATCO Pharma Launches Semaglutide Generic Injection Multi Dose Vials in India at the Most Affordable Price Starting from MRP INR 1,290
  • Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide Injection in India
  • Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India
  • Glenmark Pharmaceuticals Inc., USA to launch Potassium Phosphates Injections
  • Caplin Steriles gets USFDA approval for Potassium Phosphates Injection
  • Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP, 15 mM P/5 mL, 45 mM P/15 mL and 150 mM P/50 mL (3 mM P/mL) Single-Dose Vials
  • Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry
  • Caplin Steriles gets USFDA approval for Sodium Phosphates Injection
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial
  • Glenmark Pharmaceuticals Inc., USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial
  • Caplin Steriles gets USFDA approval for Linezolid Injection, Infusion bags
  • Caplin Steriles granted final approval by USFDA for Acetaminophen Injection, infusion bags
  • Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg - Pegfilgrastim-unne
  • Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial

Latest Post

  • Deep Industries Ltd consolidated Q4 FY2025-26 loss at Rs. 14.35 crores
  • Data Patterns India Ltd Q4FY26 PAT climbs to Rs. 138.38 crores
  • KRBL Ltd posts consolidated PAT of Rs. 155.38 crores in Q4 FY26
  • Pitti Engineering Ltd consolidated Q4 FY2026 profit declines to Rs. 26.61 crores
  • Mukand Ltd reports consolidated PAT of Rs. 554.98 crores in Q4 FY2026


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025